PI
AMED

PEAK6 Investments’s Amedisys AMED Stock Holding History

PEAK6 Investments’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,500
Closed -$788K – 4889
2022
Q2 		$788K Sell
7,500
-1,700
-18% -$217K ﹤0.01% 3323
2022
Q1 		$1.58M Sell
9,200
-3,700
-29% -$553K ﹤0.01% 2068
2021
Q4 		$2.09M Sell
12,900
-53,300
-81% -$8.57M ﹤0.01% 1850
2021
Q3 		$9.87M Buy
66,200
+16,500
+33% +$3.43M 0.02% 705
2021
Q2 		$12.2M Sell
49,700
-45,100
-48% -$11.8M 0.03% 591
2021
Q1 		$25.1M Sell
94,800
-59,000
-38% -$16.6M 0.06% 287
2020
Q4 		$45.1M Buy
153,800
+77,500
+102% +$19.9M 0.09% 185
2020
Q3 		$18M Buy
76,300
+2,200
+3% +$500K 0.04% 370
2020
Q2 		$14.7M Sell
74,100
-89,900
-55% -$16.8M 0.05% 356
2020
Q1 		$30.1M Buy
164,000
+14,400
+10% +$2.56M 0.18% 102
2019
Q4 		$25M Sell
149,600
-90,400
-38% -$13.4M 0.13% 145
2019
Q3 		$31.4M Buy
240,000
+153,200
+176% +$19.9M 0.2% 83
2019
Q2 		$10.5M Buy
+86,800
New +$10.3M 0.07% 335
2019
Q1 		– Sell
-17,100
Closed -$2M – 3757
2018
Q4 		$2M Sell
17,100
-4,300
-20% -$507K 0.01% 1225
2018
Q3 		$2.67M Buy
+21,400
New +$2.36M 0.01% 1226

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

PEAK6 Investments's AMED Position: Q1 2022 in Review

PEAK6 Investments sold out of Amedisys (AMED) in Q1 2022, closing a stake of 12,486 shares — an estimated $1.87M sold.

PEAK6 Investments first reported a position in AMED in Q4 2018 and held it in 9 quarters. The position peaked at $7.96M in Q3 2021. 328 funds tracked by Wall St. Rank hold AMED as of Q1 2022.

  • PEAK6 Investments reported no remaining Amedisys position as of Q1 2022 after selling out during the quarter.
  • PEAK6 Investments sold 12,486 Amedisys shares in Q1 2022, an estimated $1.87M.
  • PEAK6 Investments first reported a position in Amedisys in Q4 2018 and held it in 9 quarters.
  • PEAK6 Investments's Amedisys position peaked at $7.96M in Q3 2021.
  • 328 funds tracked by Wall St. Rank held Amedisys as of Q1 2022.

Based on PEAK6 Investments's 13F filing for Q1 2022, filed 13 May 2022.